Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-05-01
2007-05-01
Saunders, David A. (Department: 1644)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007230, C435S007240, C435S029000
Reexamination Certificate
active
10635010
ABSTRACT:
Disclosed are high throughput assay systems and methods for identifying agents that alter the level of surface expression of integral membrane proteins, such as cardiac ion channels, in mammalian cells. Also disclosed are therapeutic methods of using agents identified using such methods.
REFERENCES:
patent: 4202896 (1980-05-01), Gootjes
patent: 4476129 (1984-10-01), Gootjes et al.
patent: 4874765 (1989-10-01), Lapis et al.
patent: 4987084 (1991-01-01), Tedder et al.
patent: 5122453 (1992-06-01), Martin et al.
patent: 5397702 (1995-03-01), Cahalan et al.
patent: 5969102 (1999-10-01), Bram et al.
patent: 6034066 (2000-03-01), Johnson et al.
patent: 6187802 (2001-02-01), Cheetham et al.
patent: 6743797 (2004-06-01), Brown et al.
patent: 6979547 (2005-12-01), Huang
patent: 7063953 (2006-06-01), Qin et al.
patent: 7101677 (2006-09-01), Milligan et al.
patent: 2002/0068305 (2002-06-01), Woska, Jr. et al.
patent: 2003/0022205 (2003-01-01), Curtis
patent: 2004/0018566 (2004-01-01), Vallone et al.
patent: 2005/0014202 (2005-01-01), Brown et al.
patent: 0 243 903 (1987-11-01), None
patent: WO 91/01732 (1991-02-01), None
patent: WO 98/18368 (1998-05-01), None
Barclay et al (Eds.), The Leucocyte Antigen FactsBook, Second Edition, Academic Press, 1997, pp. 189-191, 316-317, 335-336, 345-346.
C. Funck-Brentano, “Rate-dependence of class III actions in the heart,” Fundam. Clin. Pharmacol., 1993, vol. 7, pp. 51-59.
Weimin Tang et al., Development and Evaluation of High Throughput Functional Assay Methods for hERG Potassium Channel, Journ. of Biomolecular Screening, vol. 6, No. 5, 2001, pp. 325-331.
Jia Xu et al., “Ion-channel assay technologies: quo vadis?” DDT, vol. 6, No. 24, Dec. 2001, pp. 1278-1287.
André Collioud et al., “Oriented and Covalent Immobilization of Target Molecules to Solid Supports: Synthesis and Application of a Light-Activatable and Thiol-Reactive Cross-Linking Reagent,” Bioconjugate Chem., vol. 4, 1993, pp. 528-536.
Lutz Schmitt et al., Specific Protein Docking to Chelator Lipid Monolayers Monitored by FT-IR Spectroscopy at the Air-Water Interface, Angew. Chem. Int. Ed. Engl., vol. 35, No. 3, 1999, pp. 317-320.
Wolfgang Schuhmann et al., “Immobilization of Enzymes on Langmuir-Blodgett Films via a Membrane-Bound Receptor. Possible Applications for Amperometric Biosensors,” Adv. Mater., vol. 3, No. 7/8, 1991, pp. 388-391.
Jamie L. Vandenberg et al., “HERG30K channels: friend and foe,” Trends Pharmacol. Sci., vol. 22, 2001, pp. 240-246.
Mary-Louis Roy, PH.D. et al., “HERG, Primary Human Ventricular Target of the Nonsedating Antihistamine Terfenadine,” Circulation, vol. 94, 1996, pp. 817-823.
Keith Finlayson et al., “[3H]Dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen,” Eur. J. Pharm, vol. 430, 2001, pp. 147-148.
Georg C. Terstappen, “Functional Analysis of Native and Recombinant Ion Channels Using a High-Capacity Nonradioactive Rubidium Efflux Assay,” Annal. Biochem., vol. 272, 1999, pp. 149-155.
E.M. Vaughan Williams, “Classification of anti-arrhythmic drugs,” Symposium on Cardiac Arrhythmias, Elsinore, Denmark, Apr. 23-25, 1970, pp. 449-472.
B.N. Singh et al., “A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474,” Br. J. Pharmacol, vol. 39, Aug. 1970, pp. 675-689.
B.N. Singh et al., “The effect of amiodarone, a new anti-anginal drug, on cardiac miscle,” Br. J. Pharmacol, vol. 39, Aug. 1970, pp. 657-667.
Koonlawee Nademanee, MD, FACC, “The Amiodarone Odyssey,” J. Am. Coll. Cardiol., vol. 20, 1992, pp. 1063-1065.
Michael C. Sanguinetti et al., “Two Components of Cardiac Delayed Rectifier K+Current: Differential Sensitivity to Block by Class III Antiarrhythmic Agents,” J. Gen. Physiol., vol. 96, No. 1, Jul. 1990, pp. 195-215.
Mark E. Curran et al., “A Molecular Basis for Cardiac Arrhythmia:HERGMutations Cause Long QT Syndrome,” Cell, vol. 80, No. 5, Mar. 10, 1995, pp. 795-803.
Jeffrey R. Balser et al., “Suppression of Time-Dependent Outward Current in Guinea Pig Ventricular Myocytes,” Circ. Res., vol. 69, No. 2, Aug. 1991, pp. 519-529.
Dan M. Roden, MD, “Current Status of Class II Antiarrhythmic Drug Therapy,” Am. J. Cardiol., vol. 72, No. 6, Aug. 26, 1993, pp. 44B-49B.
Luc M. Hondeghem, “Development of Class III Antiarrhythmic Agents,” J. Cardiovasc. Cardiol., vol. 20 Supp. 2, 1992, pp. S17-S22.
L.M. Hondeghem, MD, PhD. et al., “Class III Antiarrhythmic Agents Have a Lot of Potential but a Long Way to Go: Reduced Effectiveness and Dangers of Reverse Use Dependence,” Circulation, vol. 81, No. 2, Feb. 1990, pp. 686-690.
Tsuneaki Sadanaga, MD et al., “Clinical evaluation of the use-dependent QRS prolongation and the reverse use-dependent QT prolongation of class I and class III antiarrythmic agents and their value in predicting efficacy,” Amer. Heart Journal, vol. 126, No. 1, Jul. 1993, pp. 114-121.
Nancy K. Jurkiewicz et al., “Rate-Dependent Prolongation of Cardiac Action Potentials by a Methanesulfonanilide Class III Antiarrhythmic Agent: Specific Block of Rapidly Activating Delayed Rectifier K+Current by Dofetilide,” Circ. Res., vol. 72, No. 1, Jan. 1993, pp. 75-83.
Bin Lu et al., “Oriented Immobilization of Fab′ Fragments on Silica Surfaces,” Anal. Chem, vol. 67, No. 1, Jan. 1, 1995, pp. 83-87.
Atsuko Hikikoshi Iwane et al., “Myosin Subfragment-I Is Fully Equipped with Factors Essential for Motor Function,” Biophys. Biochem. Res. Commun., vol. 230, 1997, pp. 76-80.
Kingman Ng et al., “Engineering Protein-Lipid Interactions: Targeting of Histidine-Tagged Protein to Metal-Chelating Lipid Monolayers,” Langmuir, vol. 11, 1995, pp. 4048-4055.
Wolfgang Frey et al., “Two-dimensional protein crystallization via metal-ion coordination by naturally occurring surface histidines,” Proc. Natl. Acad. Sci. USA, vol. 93, No. 10, May 14, 1996, pp. 4937-4941.
Elizabeth W. Kubalek et al., “Two-Dimensional Crystallization of Histidine-Tagged, HIV-1 Reverse Transcriptase Promoted by a Novel Nickel-Chelating Lipid,” J. Struct. Biol., vol. 113, No. 2, Sep./Oct. 1994, pp. 117-123.
George B. Sigal et al., “A Self-Assembled Monolayer for the Binding and Study of Histidine-Tagged Proteins by Surface Plasmon Resonance,” Anal. Chem., vol. 68, No. 3, Feb. 1, 1996, pp. 490-497.
Michiko Furutani et al., “Novel Mechanism Associated With an Inherited Cardiac Arrhythmia: Defective Protein Trafficking by the Mutant HERG (G601S) Potassium Channel,” Circulation, vol. 99, No. 17, May 4, 1999, pp. 2290-2294.
David B. Lewis et al., “Oxygenated Analogues of 1-[2-(Diphenylmethoxy)ethyl]- and 1-[2-[Bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazines (GBR 12935 and GBR 12909) as Potential Extended-Action Cocaine-Abuse Therapeutic Agents,” J. Med. Chem., vol. 42, No. 24, Dec. 1999, pp. 5029-5042.
Aloke K. Dutta et al., “Positional Importance of the Nitrogen Atom in Novel Piperidine Analogs of GBR 12909: Affinity and Selectivity for the Dopamine Transporter,” Med. Chem. Res., vol. 3, No. 4, 1993, pp. 209-222.
C. Isacke, “The Adhesion Molecule Facts Book”, Second Edition, Academic Press, 2000, pp. 149-151.
Brown Arthur M.
Ficker Eckhard
Wible Barbara A.
Chan Test, Inc.
Duane Morris LLP
Saunders David A.
LandOfFree
High throughput assay systems and methods for identifying... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High throughput assay systems and methods for identifying..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High throughput assay systems and methods for identifying... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3771318